Ckd Bio
CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally. The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business. It also e… Read more
Market Cap & Net Worth: Ckd Bio (063160)
Ckd Bio (KO:063160) has a market capitalization of $72.50 Million (₩106.15 Billion) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #21817 globally and #1058 in its home market, demonstrating a 0.10% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ckd Bio's stock price ₩19350.00 by its total outstanding shares 5485959 (5.49 Million).
Ckd Bio Market Cap History: 2015 to 2026
Ckd Bio's market capitalization history from 2015 to 2026. Data shows growth from $92.47 Million to $72.50 Million (0.79% CAGR).
Ckd Bio Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ckd Bio's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Ckd Bio's market cap is 0.00 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.01x
Ckd Bio's market cap is 0.01 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $92.47 Million | $106.69 Billion | $6.65 Billion | 0.00x | 0.01x |
| 2016 | $80.29 Million | $113.01 Billion | $9.43 Billion | 0.00x | 0.01x |
| 2017 | $74.20 Million | $118.19 Billion | $8.02 Billion | 0.00x | 0.01x |
| 2018 | $72.85 Million | $124.51 Billion | $7.96 Billion | 0.00x | 0.01x |
| 2019 | $109.51 Million | $137.18 Billion | $12.26 Billion | 0.00x | 0.01x |
| 2020 | $297.40 Million | $124.60 Billion | $6.21 Billion | 0.00x | 0.05x |
| 2021 | $155.96 Million | $142.24 Billion | -$6.58 Billion | 0.00x | N/A |
| 2022 | $89.17 Million | $156.04 Billion | -$16.70 Billion | 0.00x | N/A |
| 2023 | $89.36 Million | $160.35 Billion | -$24.19 Billion | 0.00x | N/A |
| 2024 | $82.43 Million | $171.76 Billion | $8.70 Billion | 0.00x | 0.01x |
Competitor Companies of 063160 by Market Capitalization
Companies near Ckd Bio in the global market cap rankings as of March 18, 2026.
Key companies related to Ckd Bio by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Ckd Bio Historical Marketcap From 2015 to 2026
Between 2015 and today, Ckd Bio's market cap moved from $92.47 Million to $ 72.50 Million, with a yearly change of 0.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩72.50 Million | -4.91% |
| 2025 | ₩76.25 Million | -7.50% |
| 2024 | ₩82.43 Million | -7.76% |
| 2023 | ₩89.36 Million | +0.21% |
| 2022 | ₩89.17 Million | -42.83% |
| 2021 | ₩155.96 Million | -47.56% |
| 2020 | ₩297.40 Million | +171.58% |
| 2019 | ₩109.51 Million | +50.33% |
| 2018 | ₩72.85 Million | -1.83% |
| 2017 | ₩74.20 Million | -7.58% |
| 2016 | ₩80.29 Million | -13.18% |
| 2015 | ₩92.47 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Ckd Bio was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $72.50 Million USD |
| MoneyControl | $72.50 Million USD |
| MarketWatch | $72.50 Million USD |
| marketcap.company | $72.50 Million USD |
| Reuters | $72.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.